Transcriptome analysis identifies metallothionein as biomarkers to predict recurrence in hepatocellular cacinoma
Abstract Background Liver cancer is the fifth most common cancer, and hepatocellular carcinoma (HCC) is the major liver tumor type seen in adults. HCC is usually caused by chronic liver disease such as hepatitis B virus or hepatitis C virus infection. One of the promising treatments for HCC is liver...
Main Authors: | Sufang Wang, Michael Gribskov |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.693 |
Similar Items
-
Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma
by: Feng Zhang, et al.
Published: (2021-10-01) -
Genomewide transcriptomic profiling identifies a gene signature for predicting recurrence in early‐stage hepatocellular carcinoma
by: Tatsuhiko Kakisaka, et al.
Published: (2021-06-01) -
Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence
by: Ping Yan, et al.
Published: (2021-04-01) -
Metallothionein and Glutathione Content as Biomarkers of Metal Pollution in Mussels and Local Fishermen in Abu Qir Bay, Egypt
by: Aziza A. Saad, et al.
Published: (2016-01-01) -
The roles of metallothioneins in carcinogenesis
by: Manfei Si, et al.
Published: (2018-08-01)